Wagenfeld A[au] - Search Results

Year	Number of Results
1994	1
1997	1
1998	3
2000	2
2002	2
2003	3
2004	2
2009	1
2013	1
2016	1
2018	2
2020	1
2021	1
2024	1
2025	0

1

Expression and cellular localization of contraception-associated protein.

Wagenfeld A, Yeung CH, Shivaji S, Sundareswaran VR, Ariga H, Cooper TG. Wagenfeld A, et al. J Androl. 2000 Nov-Dec;21(6):954-63. J Androl. 2000. PMID: 11105923 Free article.

2

The oral IRAK4 inhibitors zabedosertib and BAY1830839 suppress local and systemic immune responses in a randomized trial in healthy male volunteers.

Jodl SJ, Ten Voorde W, Klein S, Wagenfeld A, Zollmann FS, Feldmüller M, Klarenbeek NB, de Bruin DT, Jansen MAA, Rissmann R, Rohde B, Moerland M. Jodl SJ, et al. Among authors: wagenfeld a. Clin Transl Sci. 2024 Mar;17(3):e13771. doi: 10.1111/cts.13771. Clin Transl Sci. 2024. PMID: 38511583 Free PMC article. Clinical Trial.

3

Impact of a nature-based intervention on incarcerated women.

Toews B, Wagenfeld A, Stevens J. Toews B, et al. Among authors: wagenfeld a. Int J Prison Health. 2018 Dec 17;14(4):232-243. doi: 10.1108/IJPH-12-2017-0065. Int J Prison Health. 2018. PMID: 30468112

4

Male contraception-a topic with many facets.

Lye RJ, Sipilä P, Vernet P, Wagenfeld A. Lye RJ, et al. Among authors: wagenfeld a. Mol Cell Endocrinol. 2004 Mar 15;216(1-2):75-82. doi: 10.1016/j.mce.2003.10.071. Mol Cell Endocrinol. 2004. PMID: 15109747 Review.

5

Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies.

Wagenfeld A, Saunders PT, Whitaker L, Critchley HO. Wagenfeld A, et al. Expert Opin Ther Targets. 2016 Sep;20(9):1045-54. doi: 10.1080/14728222.2016.1180368. Epub 2016 May 14. Expert Opin Ther Targets. 2016. PMID: 27138351 Free PMC article. Review.

6

Mouse models of infertility due to swollen spermatozoa.

Cooper TG, Yeung CH, Wagenfeld A, Nieschlag E, Poutanen M, Huhtaniemi I, Sipilä P. Cooper TG, et al. Among authors: wagenfeld a. Mol Cell Endocrinol. 2004 Mar 15;216(1-2):55-63. doi: 10.1016/j.mce.2003.10.076. Mol Cell Endocrinol. 2004. PMID: 15109745 Review.

7

BAY 1002670: a novel, highly potent and selective progesterone receptor modulator for gynaecological therapies.

Wagenfeld A, Bone W, Schwede W, Fritsch M, Fischer OM, Moeller C. Wagenfeld A, et al. Hum Reprod. 2013 Aug;28(8):2253-64. doi: 10.1093/humrep/det247. Epub 2013 Jun 5. Hum Reprod. 2013. PMID: 23739217

8

Coping on the inside: Design for therapeutic incarceration interventions - A case study.

Wagenfeld A, Winterbottom D. Wagenfeld A, et al. Work. 2021;68(1):97-106. doi: 10.3233/WOR-203360. Work. 2021. PMID: 33427712

9

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies.

Möller C, Bone W, Cleve A, Klar U, Rotgeri A, Rottmann A, Schultze-Mosgau MH, Wagenfeld A, Schwede W. Möller C, et al. Among authors: wagenfeld a. ChemMedChem. 2018 Nov 6;13(21):2271-2280. doi: 10.1002/cmdc.201800487. ChemMedChem. 2018. PMID: 30407750 Free PMC article.

10

Molecular cloning and expression of rat contraception associated protein 1 (CAP1), a protein putatively involved in fertilization.

Wagenfeld A, Gromoll J, Cooper TG. Wagenfeld A, et al. Biochem Biophys Res Commun. 1998 Oct 20;251(2):545-9. doi: 10.1006/bbrc.1998.9512. Biochem Biophys Res Commun. 1998. PMID: 9792810

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Results by year